Melanoma (Skin) Stage IV Completed Phase 2 Trials for Selumetinib (DB11689)

Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma

IndicationStatusPhase
DBCOND0109891 (Melanoma (Skin) Stage IV)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00866177MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV MelanomaTreatment